Norris Medicines submits standalone un-audited financial results

06 Feb 2020 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of Standalone Un-audited Financial Results of the Company for the Quarter and nine month ended on 31st December, 2019; and Limited Review Report by Statutory Auditors on Standalone Un-audited Financial Results for the quarter and nine month ended on 31st December, 2019.

The above information is a part of company's filings submitted to BSE.

Norris Medicines Share Price

13.67 -0.53 (-3.73%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×